CALLAN JMB INC.
No SEC Form 4 filings for $CJMB in the last 30 days.
See all $CJMB insider activity →Nasdaq notified Callan JMB (CJMB) of delisting due to insufficient stockholders' equity. The company requested a hearing, which temporarily halts trading suspension. Success of the appeal is uncertain.
Callan JMB Inc. (CJMB) announced a $28M equipment investment for U.S. pharmaceutical manufacturing at the Atlas Complex in Alabama, partnering with TRUKING. The company will also distribute and assemble TRUKING equipment, expanding its role in pharmaceutical infrastructure. Initial production is targeted for late 2027, subject to regulatory approvals.
CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously reported, on August 19, 2026, Callan JMB Inc. (the “Company”), together with its wholly owned subsidiary Call
Over the past 7 days, AlphAI's AI scored 1 news story mentioning CJMB (CALLAN JMB INC.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent CJMB coverage spans corporate actions, financial news and mergers & acquisitions.
The delisting notice creates significant downside risk as the stock may be suspended or lose listing status.
Positive medium-term outlook as CJMB moves from logistics into domestic pharma manufacturing support, but near-term execution risk is meaningful.
Board change may affect governance perception but no immediate financial impact.
The acquisition expands Callan JMB's upstream exposure and may boost future production revenues.
The deal is cash‑accretive and diversifies Callan Power's energy footprint, likely supporting the stock price.
AlphAI scores every news story that mentions CJMB with an AI model for sentiment and relevance, and aggregates insider trades from CALLAN JMB INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Nasdaq notified Callan JMB (CJMB) of delisting due to insufficient stockholders' equity. The company requested a hearing, which temporarily halts trading suspension. Success of the appeal is uncertain.
1 min readCallan JMB Inc. (CJMB) announced a $28M equipment investment for U.S. pharmaceutical manufacturing at the Atlas Complex in Alabama, partnering with TRUKING. The company will also distribute and assemble TRUKING equipment, expanding its role in pharmaceutical infrastructure. Initial production is targeted for late 2027, subject to regulatory approvals.
5 min readCALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously reported, on August 19, 2026, Callan JMB Inc. (the “Company”), together with its wholly owned subsidiary Call
1 min readCALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 26, 2026, Callan Power LLC, a Nevada limited liability company (“ Buyer ”) and a subsidiary of Callan JMB Inc. (the “ Company ”), entered into an Asset Purchase and Sale Agreement (the “ APA ”) with The Pfanenstiel
2 min readCallan JMB Inc. (CJMB) will acquire oil and gas assets in the Williston Basin for $12.5M, adding 377 wells and 150 BOE/day production. The deal, expected to close by October 2026, includes $48.1M in proved PV-10 reserves and $82.7M in 3P PV-10 reserves, with an estimated 21.2% unlevered cash return at $75 WTI.
2 min readCALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 19, 2026, Callan JMB Inc., a Nevada corporation (the “ Company ”), together with its wholly owned subsidiary Callan Power LLC, a Nevada limited liability company (“ Buyer ”), entered into an Asset Purchase and Sale
1 min readCALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 18, 2026, Callan JMB Inc., a Nevada corporation (the “ Company ”), entered into a First Amended and Restated Purchase Agreement (the “ Amended Purchase Agreement ”) with a certain investor (the “ Investor ”), which
2 min readCallan JMB Inc. (NASDAQ:CJMB) shares rose about 49.8% to $1.29 after hours after the company said it signed a strategic partnership with Alabama State University to build an integrated pharmaceutical manufacturing ecosystem. Callan will provide logistics and regulatory support and receive 21% of qualifying gross revenue. Management projected annual gross revenues near $500 million, about $105 million for the company. The stock also faces a Nasdaq $1 bid compliance deadline.
4 min readCallan JMB Inc. (NASDAQ: CJMB) said it has partnered with Alabama State University to support workforce development and applied research at Atlas Complex in Marion, Alabama. The planned 150-acre pharmaceutical and medical logistics campus aims to support U.S. pharmaceutical onshoring and domestic supply chains, targeting more than $430 million in annual revenue at maturity.
3 min readCALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 Settlement, Waiver and Release Agreement This Settlement, Waiver and Release Agreement (“ Agreement ” or “ Settlement Agreement ”) is made and entered into as of June 5, 2026 (“ Effective Date ”) by and between CALLAN JMB Inc., a Nevada C
4 min read
